News &amp; Updates

Individuals with binge-eating disorder (BED) and obesity who responded well to combination treatment with naltrexone plus bupropion may benefit from receiving maintenance treatment with the same combination, according to a study.

Improved binge eating outcomes with naltrexone/bupropion? Extended treatment recommended

Patient-tailored interventions improve specialty medication adherence

Patient-tailored interventions have led to significant improvements in adherence to specialty medications when compared with standard of care, according to a study

Patient-tailored interventions improve specialty medication adherence

RAS inhibitors proven beneficial in HFrEF with advanced kidney disease

Use of renin-angiotensin system (RAS) inhibitors results in improved clinical outcomes in patients with heart failure with reduced ejection fraction (HFrEF) and advanced kidney disease, a study has shown.

RAS inhibitors proven beneficial in HFrEF with advanced kidney disease

06 Jul 2023

More evidence for COVID-19 vaccine safety in kids

COVID-19 vaccines can be safely administered in children, with a recent study showing that out of the numerous health outcomes monitored in near real time, the safety signal identified was for only myocarditis or pericarditis.

More evidence for COVID-19 vaccine safety in kids

05 Jul 2023

Is it safe to use biologic drugs in pregnancy?

05 Jul 2023 by

Among the biologic drugs used during pregnancy, the most common is tumour necrosis factor-α antagonist (etanercept-infliximab-adalimumab), results of a clinical review have shown.

Is it safe to use biologic drugs in pregnancy?

Semaglutide a useful weight-loss treatment option for men, women

In the treatment of obesity, semaglutide works for both men and women, according to the results of a network meta-analysis.

Semaglutide a useful weight-loss treatment option for men, women

Paternal methotrexate use confers no teratogenic effects but may temporarily reduce fertility

The periconceptional use of methotrexate among men does not contribute to an increase in the risk of congenital anomalies, preterm birth (PTB), and being small for gestational age (SGA), but it may lead to a temporary decrease in fertility, according to a study.

Paternal methotrexate use confers no teratogenic effects but may temporarily reduce fertility

ADHD meds emerge as preferred option for reducing self-harm risk in BPD

04 Jul 2023 by

For individuals with bipolar disorder (BPD), attention-deficit/hyperactive disorder (ADHD) medications help lower the risk of suicidal behaviour, according to data from a comparative effectiveness research study.

ADHD meds emerge as preferred option for reducing self-harm risk in BPD

04 Jul 2023

Migraine tied to adverse pregnancy outcomes

04 Jul 2023 by

Pregnant women with migraine appear to have an increased likelihood of experiencing pre-eclampsia, low birth weight, peripartum mental illness, preterm birth, and placental abruption, according to a study presented at the recent RCOG 2023.

Migraine tied to adverse pregnancy outcomes

Lower LDL-C target a better bet for adverse CV event prevention after stroke

A treatment strategy of targeting a low-density lipoprotein cholesterol (LDL-C) of <70 mg/dL leads to a significant reduction in the composite of adverse cardiovascular (CV) events in patients who have had stroke as compared with an LDL-C target of 100 mg/dL, according to data from the Treat Stroke to Target (TST) trial.

Lower LDL-C target a better bet for adverse CV event prevention after stroke